ASD Defiance Autism Impact ETF
Issuer
Defiance
Inception
Jun 1, 2026
AUM
$1.4M
Expense ratio
0.79%
Yield
0.03%
Asset class
Equity
Holdings
40
Last price
$27.46
It operates as an exchange-traded investment fund.
+11.3%
2026-06-02low 24.59 · high 28.522026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| ASD | +4.3% | -1.1% | +11.5% | +11.5% | +3.7% | +2.2% |
| Equity average (4725 funds) | -2.2% | -4.7% | +3008.3% | +1886.0% | +15.1% | +2.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$968K net.
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | ACHC Acadia Healthcare Co Inc | 3.51% |
| 2 | RVTY Revvity Inc | 3.43% |
| 3 | HLUN-B.CO H Lundbeck A/S | 3.35% |
| 4 | LLY Eli Lilly & Co | 3.32% |
| 5 | BTSG BrightSpring Health Services Inc | 3.27% |
| 6 | 4506.T Sumitomo Pharma Co Ltd | 3.23% |
| 7 | TEVA.TA Teva Pharmaceutical Industries Ltd | 3.17% |
| 8 | 4502.T Takeda Pharmaceutical Co Ltd | 3.11% |
| 9 | NOVN.SW Novartis AG | 3.09% |
| 10 | ROP.SW Roche Holding AG | 3.05% |
| 11 | ABBV AbbVie Inc | 3.04% |
| 12 | NEU.AX Neuren Pharmaceuticals Ltd | 2.95% |
| 13 | PSON.L Pearson PLC | 2.94% |
| 14 | LFST LifeStance Health Group Inc | 2.88% |
| 15 | 4507.T Shionogi & Co Ltd | 2.86% |
| 16 | MCOV-B.ST Medicover AB | 2.85% |
| 17 | GHC Graham Holdings Co | 2.83% |
| 18 | JNJ Johnson & Johnson | 2.81% |
| 19 | 4578.T Otsuka Holdings Co Ltd | 2.79% |
| 20 | GSK.L GSK PLC | 2.77% |
| 21 | PFE Pfizer Inc | 2.76% |
| 22 | IPN.PA Ipsen SA | 2.69% |
| 23 | RGEN Repligen Corp | 2.67% |
| 24 | JAZZ Jazz Pharmaceuticals PLC | 2.66% |
| 25 | LHC.JO Life Healthcare Group Holdings Ltd | 2.65% |
| 26 | ASD KPJ Healthcare Bhd | 2.60% |
| 27 | BMY Bristol-Myers Squibb Co | 2.59% |
| 28 | LRN Stride Inc | 2.44% |
| 29 | DFTX Definium Therapeutics Inc | 2.32% |
| 30 | BMRN BioMarin Pharmaceutical Inc | 2.29% |
| 31 | BFAM Bright Horizons Family Solutions Inc | 2.18% |
| 32 | VNDA Vanda Pharmaceuticals Inc | 2.08% |
| 33 | LOPE Grand Canyon Education Inc | 2.06% |
| 34 | BWAY Brainsway Ltd | 1.95% |
| 35 | ACAD ACADIA Pharmaceuticals Inc | 1.73% |
| 36 | MPLT MapLight Therapeutics Inc | 1.36% |
| 37 | AVXL Anavex Life Sciences Corp | 0.99% |
Sector breakdown
Healthcare87.2%
Consumer Defensive4.6%
Communication Services3.0%
Industrials2.9%
Consumer Cyclical2.3%
Country breakdown
United States56.9%
Japan11.7%
Switzerland6.2%
United Kingdom5.7%
Israel5.1%
Denmark3.4%
Sweden2.9%
South Africa2.7%
France2.7%
Malaysia2.7%
Distributions
| Date | Per unit |
|---|---|
| Sep 23, 2026 | $0.0020 |
| Jun 24, 2026 | $0.0060 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in ASD in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error